User profiles for Carol O’Brien

Carol O'Brien

Trinity College Dublin
Verified email at tcd.ie
Cited by 1232

Identification of common variants associated with human hippocampal and intracranial volumes

…, SM Maniega, K Nho, AC Nugent, C O'brien… - Nature …, 2012 - nature.com
Identifying genetic variants influencing human brain structures may reveal new biological
mechanisms underlying cognition and neuropsychiatric illness. The volume of the …

In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models

KP Hoeflich, C O'Brien, Z Boyd, G Cavet… - Clinical Cancer …, 2009 - AACR
Purpose: The pathways underlying basal-like breast cancer are poorly understood, and as
yet, there is no approved targeted therapy for this disease. We investigated the role of mitogen…

De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability

…, E Ghiban, E Antoniou, E Kelleher, C O'Brien… - Molecular …, 2014 - nature.com
Schizophrenia is a serious psychiatric disorder with a broadly undiscovered genetic etiology.
Recent studies of de novo mutations (DNMs) in schizophrenia and autism have reinforced …

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

…, MR Lackner, AT Adai, N Yu, HJ Kim, C O'Brien… - Science …, 2011 - science.org
The basal-like subtype of breast cancer has an aggressive clinical behavior compared to
that of the luminal subtype. We identified the microRNAs (miRNAs) miR-221 and miR-222 (miR-…

Predictive biomarkers of sensitivity to the phosphatidylinositol 3′ kinase inhibitor GDC-0941 in breast cancer preclinical models

C O'Brien, JJ Wallin, D Sampath, D GuhaThakurta… - Clinical cancer …, 2010 - AACR
Purpose: The class I phosphatidylinositol 3′ kinase (PI3K) plays a major role in proliferation
and survival in a wide variety of human cancers. A key factor in successful development of …

Genetic alterations and oncogenic pathways associated with breast cancer subtypes

X Hu, HM Stern, L Ge, C O'Brien, L Haydu… - Molecular cancer …, 2009 - AACR
Breast cancers can be divided into subtypes with important implications for prognosis and
treatment. We set out to characterize the genetic alterations observed in different breast …

GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway

…, L Salphati, AG Olivero, DP Sutherlin, C O'Brien… - Molecular cancer …, 2011 - AACR
Alterations of the phosphoinositide-3 kinase (PI3K)/Akt signaling pathway occur broadly in
cancer via multiple mechanisms including mutation of the PIK3CA gene, loss or mutation of …

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer

…, MR Lackner, AT Adai, N Yu, HJ Kim, C O'Brien… - Science …, 2011 - science.org
Compared with the luminal subtype, the basal-like subtype of breast cancer has an aggressive
clinical behavior, but the reasons for this difference between the two subtypes are poorly …

ERK inhibition overcomes acquired resistance to MEK inhibitors

G Hatzivassiliou, B Liu, C O'Brien, JM Spoerke… - Molecular cancer …, 2012 - AACR
The RAS/RAF/MEK pathway is activated in more than 30% of human cancers, most commonly
via mutation in the K-ras oncogene and also via mutations in BRAF. Several allosteric …

Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer …

JM Spoerke, C O'Brien, L Huw, H Koeppen… - Clinical cancer …, 2012 - AACR
Purpose: Class 1 phosphatidylinositol 3-kinase (PI3K) plays a major role in cell proliferation
and survival in a wide variety of human cancers. Here, we investigated biomarker strategies …